Table 1.
Tissue type | Total (n) | Low immunoreactivity score, n (%)a | High immunoreactivity score, n (%)a | Significanceb |
---|---|---|---|---|
HuR | ||||
Normal | 81 | 53 (65.4) | 28 (34.6) | |
Adenoma | 38 | 11 (28.9) | 27 (71.1) | <.0001 |
Adenocarcinoma | 76 | 13 (17.1) | 63 (82.9) | <.0001 |
TTP | ||||
Normal | 82 | 10 (12.2) | 72 (87.8) | |
Adenoma | 42 | 33 (78.6) | 9 (21.4) | .00019 |
Adenocarcinoma | 82 | 65 (79.3) | 17 (20.7) | <.0001 |
COX-2 | ||||
Normal | 81 | 70 (87.0) | 11 (13.0) | |
Adenoma | 41 | 16 (39.0) | 25 (61.0) | <.0001 |
Adenocarcinoma | 78 | 17 (21.8) | 61 (78.2) | <.0001 |
Immunoreactivity score for each tissue was on a scale of 0 to 12 as indicated in Materials and Methods section; low immunoreactivity score distribution ranged from 0 to 6, and high immunoreactivity score distribution ranged from 7 to 12.
χ2 Test.